Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Marchetti

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
The Journal of Organic Chemistry|October 15, 2022
A Unique and Stable Polyproline I Helix Sorted out from Conformational Equilibrium by Solvent PolarityMatteo Pollastrini, Luca Pasquinelli, Marcin Górecki, et al.
Inorganic Chemistry|June 11, 2009
Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligandsFabio Marchetti, Claudio Pettinari, Adele Cerquetella, et al.
Dalton Transactions (Cambridge, England : 2003)|July 8, 2025
Ruthenium(II)-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductaseSara Pagliaricci, Noemi Pagliaricci, Alessia Tombesi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 31, 2022
Automated approach for the evaluation of glutathione-S-transferase P1-1 inhibition by organometallic anticancer compoundsSarah A P Pereira, A Catarina Baptista L, Lorenzo Biancalana, et al.
Journal of Medicinal Chemistry|April 19, 2024
FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In VivoEkatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 26, 2025
Circularly Polarized Luminescence From Spontaneous Symmetry Breaking in a Bimetallic Eu-Al ComplexMarcin Górecki, Elisa Gallo, Luca Bellucci, et al.
Metallomics : Integrated Biometal Science|December 14, 2022
The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexesBeatrice Campanella, Simona Braccini, Giulio Bresciani, et al.
Chemmedchem|November 9, 2019
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene ComplexesMassimiliano Cuccioloni, Laura Bonfili, Valentina Cecarini, et al.
Dalton Transactions (Cambridge, England : 2003)|October 31, 2022
Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligandsAlberto Gobbo, Sarah A P Pereira, Lorenzo Biancalana, et al.
Chemmedchem|September 22, 2012
Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis inductionLaura Bonfili, Riccardo Pettinari, Massimiliano Cuccioloni, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Organic Chemistry|October 15, 2022
A Unique and Stable Polyproline I Helix Sorted out from Conformational Equilibrium by Solvent PolarityMatteo Pollastrini, Luca Pasquinelli, Marcin Górecki, et al.
Inorganic Chemistry|June 11, 2009
Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligandsFabio Marchetti, Claudio Pettinari, Adele Cerquetella, et al.
Dalton Transactions (Cambridge, England : 2003)|July 8, 2025
Ruthenium(II)-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductaseSara Pagliaricci, Noemi Pagliaricci, Alessia Tombesi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 31, 2022
Automated approach for the evaluation of glutathione-S-transferase P1-1 inhibition by organometallic anticancer compoundsSarah A P Pereira, A Catarina Baptista L, Lorenzo Biancalana, et al.
Journal of Medicinal Chemistry|April 19, 2024
FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In VivoEkatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 26, 2025
Circularly Polarized Luminescence From Spontaneous Symmetry Breaking in a Bimetallic Eu-Al ComplexMarcin Górecki, Elisa Gallo, Luca Bellucci, et al.
Metallomics : Integrated Biometal Science|December 14, 2022
The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexesBeatrice Campanella, Simona Braccini, Giulio Bresciani, et al.
Chemmedchem|November 9, 2019
Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene ComplexesMassimiliano Cuccioloni, Laura Bonfili, Valentina Cecarini, et al.
Dalton Transactions (Cambridge, England : 2003)|October 31, 2022
Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligandsAlberto Gobbo, Sarah A P Pereira, Lorenzo Biancalana, et al.
Chemmedchem|September 22, 2012
Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis inductionLaura Bonfili, Riccardo Pettinari, Massimiliano Cuccioloni, et al.
Pageof 26